Subjects with a high risk of developing T1DM and newly diagnosed T1DM patients have lower circulating levels of neutrophils [139–142], which correlate with reduced serum levels of NE and PR3 [143] and faster disease progression [142, 144]. This evidence concerns the gene PRTN3 and type 1 diabetes mellitus.